20 February 2018 - The national EpiPen shortage could have been avoided if there was another adrenaline injector on the Pharmaceutical Benefits Scheme.
That is the message from Tasmanian branch president of the Pharmacy Guild of Australia John Dowling.
Mr Dowling said the guild wanted an EpiPen alternative called Adrenaject, made by Sun Pharma, added to the federal government scheme.